Robert A. D. Hull

504 total citations
23 papers, 304 citations indexed

About

Robert A. D. Hull is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert A. D. Hull has authored 23 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert A. D. Hull's work include Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (6 papers) and Peptidase Inhibition and Analysis (3 papers). Robert A. D. Hull is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (6 papers) and Peptidase Inhibition and Analysis (3 papers). Robert A. D. Hull collaborates with scholars based in United Kingdom, United States and Norway. Robert A. D. Hull's co-authors include V.P. Gerskowitch, Nigel P. Shankley, J.W. Black, John Hay, Francesco Grieco, Elaine A. Harper, S. Barret Kalindjian, L.A. Bishop, Dustin Thomas and Iain M. McDonald and has published in prestigious journals such as Gastroenterology, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Robert A. D. Hull

22 papers receiving 298 citations

Peers

Countries citing papers authored by Robert A. D. Hull

Since Specialization

Citations

This map shows the geographic impact of Robert A. D. Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. D. Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. D. Hull more than expected).

Fields of papers citing papers by Robert A. D. Hull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. D. Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. D. Hull. The network helps show where Robert A. D. Hull may publish in the future.

Co-authorship network of co-authors of Robert A. D. Hull

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. D. Hull. A scholar is included among the top collaborators of Robert A. D. Hull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. D. Hull. Robert A. D. Hull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adoption of coronary artery disease - Reporting and Data System (CAD-RADS™) and observed impact on medical therapy and systolic blood pressure control 2020 ·Journal of cardiovascular computed tomography ·Robert A. D. Hull, (unknown), (unknown), (unknown), (unknown), (unknown), Christopher D. Maroules, Ricardo C. Cury, Dustin Thomas	4
2	Adoption of the Coronary Artery Disease-reporting and Data System: Reduced Downstream Testing and Cardiology Referral Rates in Patients with Non-obstructive Coronary Artery Disease 2019 ·Cureus ·(unknown), Robert A. D. Hull, (unknown), (unknown), (unknown), (unknown), Christopher D. Maroules, Ricardo C. Cury, Dustin Thomas	5
3	Left atrial appendage morphology and risk of stroke following pulmonary vein isolation for drug-refractory atrial fibrillation in low CHA2DS2Vasc risk patients 2017 ·BMC Cardiovascular Disorders ·(unknown), Robert A. D. Hull, (unknown), (unknown), (unknown), Ahmad Slim, Dustin Thomas	5
4	Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials 2006 ·British Journal of Cancer ·Ian Chau, David Cunningham, Christopher Russell, A. Norman, Tom Kurzawinski, Peter Harper, Phil Harrison, Gary Middleton, (unknown), Tamas Hickish, (unknown), Paul J. Ross, B Theis, Robert A. D. Hull, Michael Walker, Nigel P. Shankley, (unknown), Gordon Murray, Angela Gillbanks, (unknown)	62
5	Unexpected relationship between plasma protein binding and the pharmacodynamics of 2‐NAP, a CCK1‐receptor antagonist 2006 ·British Journal of Clinical Pharmacology ·V.P. Gerskowitch, Jeffrey P. Hodge, Robert A. D. Hull, Nigel P. Shankley, S. Barret Kalindjian, John McEwen, J.W. Black	8
6	Novel, Achiral 1,3,4-Benzotriazepine Analogues of 1,4-Benzodiazepine-Based CCK₂ Antagonists That Display High Selectivity over CCK₁ Receptors 2006 ·Journal of Medicinal Chemistry ·Iain M. McDonald, Carol Austin, Ildiko M. Buck, (unknown), (unknown), Elaine A. Harper, Robert A. D. Hull, S. Barret Kalindjian, Ian D. Linney, Caroline M. R. Low, Michael J. Pether, John Spencer, (unknown), Trushar Adatia, Alan Bashall	32
7	222 Gastrazole, a novel CCKB/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials 2003 ·European Journal of Cancer Supplements ·Ian Chau, David Cunningham, (unknown), (unknown), (unknown), Paul J. Harrison, Paul J. Ross, Robert A. D. Hull, (unknown), (unknown)	2
8	Use of a novel CCKB/gastrin receptor antagonist, gastrazole (JB5008) in patients with advanced pancreatic adenocarcinoma. Results of an open labeled pilot trial 2001 ·Gastroenterology ·Michael A. Heneghan, Robert A. D. Hull, Pauline Kane, Nigel P. Shankley, S. Barret Kalindjian, J. Michael Tredger, J.W. Black, Philip M. Harrison	5
9	Development of Peptide 3D Structure Mimetics: Rational Design of Novel Peptoid Cholecystokinin Receptor Antagonists 2000 ·Journal of Medicinal Chemistry ·Caroline M. R. Low, J.W. Black, Howard B. Broughton, Ildiko M. Buck, (unknown), (unknown), Robert A. D. Hull, S. Barret Kalindjian, Iain M. McDonald, Michael J. Pether, Nigel P. Shankley, (unknown)	13
10	Analysis of the variation in the action of L‐365,260 at CCK_B/gastrin receptors in rat, guinea‐pig and mouse isolated gastric tissue assays 1996 ·British Journal of Pharmacology ·(unknown), Elaine A. Harper, Gillian F. Watt, V.P. Gerskowitch, Robert A. D. Hull, Nigel P. Shankley, J.W. Black	15
11	The use of receptor desensitization to analyse CCK_A and CCK_B/gastrin receptors coupled to contraction in guinea‐pig stomach muscle 1995 ·British Journal of Pharmacology ·L.A. Bishop, V.P. Gerskowitch, Robert A. D. Hull, Nigel P. Shankley, J.W. Black	7
12	Kallikrein rK10‐induced kinin‐independent, direct activation of NO‐formation and relaxation of rat isolated aortic rings 1995 ·British Journal of Pharmacology ·(unknown), Robert A. D. Hull, V.P. Gerskowitch, Torill Berg	6
13	2‐Naphthalenesulphonyl l‐aspartyl‐(2‐phenethyl)amide (2‐NAP)‐a selective cholecystokinin CCK_A‐receptor antagonist 1993 ·British Journal of Pharmacology ·Robert A. D. Hull, Nigel P. Shankley, Elaine A. Harper, V.P. Gerskowitch, J.W. Black	31
14	Synthesis and pharmacological properties of BW315c and other inotropic 2-arylimidazo[1,2-a]pyrazines 1993 ·Bioorganic & Medicinal Chemistry Letters ·Paul Barraclough, J.W. Black, D. Cambridge, V.P. Gerskowitch, Heather Giles, Robert C. Glen, Robert A. D. Hull, (unknown), (unknown), M. S. NOBBS, Peter Randall, (unknown), David A. Stone, (unknown), (unknown)	6
15	An improved procedure for the purification of protein fused with glutathione S-transferase. 1992 ·PubMed ·Francesco Grieco, John Hay, Robert A. D. Hull	45
16	Combined dose‐ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea‐pig gall bladder 1992 ·British Journal of Pharmacology ·L.A. Bishop, V.P. Gerskowitch, Robert A. D. Hull, Nigel P. Shankley, J.W. Black	20
17	Inotropic Polyazapentalene Sulmazole Analogues 1992 ·Archiv der Pharmazie ·Paul Barraclough, J.W. Black, D. Cambridge, David Firmin, V.P. Gerskowitch, (unknown), Heather Giles, (unknown), Robert A. D. Hull, (unknown), Peter Randall, (unknown), (unknown), (unknown)	7
18	Characterization of a new kallikrein-like enzyme (KLP-S3) of the rat submandibular gland 1992 ·Biochemical Journal ·Trond Berg, (unknown), (unknown), Robert A. D. Hull, V.P. Gerskowitch, (unknown)	12
19	Inotropic Activities of Imidazopyridines 1990 ·Archiv der Pharmazie ·Paul Barraclough, J.W. Black, D. Cambridge, V.P. Gerskowitch, Robert A. D. Hull, (unknown), (unknown), Clare O. Kneen, M. S. NOBBS, (unknown), (unknown), (unknown), (unknown)	4
20	Cardiotonic ‘C’ Ring Modified Isomazole Analogues 1990 ·Archiv der Pharmazie ·Paul Barraclough, J.W. Black, D. Cambridge, (unknown), V.P. Gerskowitch, Heather Giles, Alan P. Hill, Robert A. D. Hull, (unknown), (unknown), David J. Livingstone, M. S. NOBBS, Peter Randall, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact